| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-09 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.3 | 2e-09 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-08 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-07 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-06 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-06 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-06 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-06 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.13 | 9e-06 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.15 | 9e-06 |